美股市場個股詳情
MXCT MaxCyte
- 3.758
- -0.023-0.60%
交易中 05/02 11:07 (美東)
3.93億總市值-10155市盈率TTM
3.800最高價3.620最低價13.85萬股成交量3.800今開3.780昨收51.19萬成交額0.15%換手率虧損市盈率(靜)1.05億總股本5.54552周最高1.69市淨率3.45億流通值2.45052周最低--股息TTM9185.86萬流通股17.440歷史最高--股息率TTM4.76%振幅2.450歷史最低3.696平均價1股每手
MaxCyte股票討論區
登錄發表評論
專欄Today's pre-market stock movers: DAL, JPM, NSTG, ATRS and more
Gainers:
•$Antares Pharma(ATRS.US$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
•$Sierra Oncology(SRRA.US$ +37.9% (acquired by GSK for $55 per share)
•$Amryt Pharma(AMYT.US$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
•$BriaCell Therapeutics(BCTX.US$ +6% (presents development details of...
•$Antares Pharma(ATRS.US$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
•$Sierra Oncology(SRRA.US$ +37.9% (acquired by GSK for $55 per share)
•$Amryt Pharma(AMYT.US$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
•$BriaCell Therapeutics(BCTX.US$ +6% (presents development details of...
12
4
$MaxCyte(MXCT.US$ come riseee
1
1
暫無評論
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
Vhetration69 : d
SLLS : 尼斯
Be a voice no echo : 向上
Trytosaveabit Be a voice no echo: 第三階段的成果很棒！